Eli Lilly and Co
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 43K
- Market Cap
- $859.4B
- Introduction
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer
- Conditions
- Breast CancerNeoplasm MetastasisColorectal Neoplasms
- Interventions
- First Posted Date
- 2014-04-28
- Last Posted Date
- 2020-04-01
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 167
- Registration Number
- NCT02124148
- Locations
- 🇺🇸
Sarah Cannon Research Institute SCRI, Nashville, Tennessee, United States
🇺🇸Tennessee Oncology PLLC, Nashville, Tennessee, United States
🇺🇸University of Texas MD Anderson Cancer Center, Houston, Texas, United States
A Study of Cephalexin Liquid for Pediatrics in Healthy Adults Participants
- First Posted Date
- 2014-04-25
- Last Posted Date
- 2015-06-25
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 28
- Registration Number
- NCT02123472
- Locations
- 🇲🇽
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mexico City, Mexico
A Study of Cephalexin Capsules in Healthy Participants
- First Posted Date
- 2014-04-25
- Last Posted Date
- 2015-07-15
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 28
- Registration Number
- NCT02123446
- Locations
- 🇲🇽
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mexico City, Mexico
A Study of Cephalexin Suspension in Healthy Participants
- First Posted Date
- 2014-04-25
- Last Posted Date
- 2015-05-27
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 28
- Registration Number
- NCT02123459
- Locations
- 🇲🇽
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mexico City, Mexico
A Study of LY3050258 in Healthy Participants
- Conditions
- Healthy Volunteers
- Interventions
- Drug: LY3050258Drug: Placebo
- First Posted Date
- 2014-04-24
- Last Posted Date
- 2018-07-27
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 63
- Registration Number
- NCT02121834
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Cypress, California, United States
A Study of LY2835219 in Participants With Cancer
- Conditions
- NeoplasmNeoplasm Metastasis
- Interventions
- First Posted Date
- 2014-04-21
- Last Posted Date
- 2019-01-07
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 26
- Registration Number
- NCT02117648
- Locations
- 🇺🇸
Accelerated Comm. Oncology Research Network (ACORN), Memphis, Tennessee, United States
🇺🇸The West Clinic, Memphis, Tennessee, United States
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2014-04-10
- Last Posted Date
- 2019-10-09
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 174
- Registration Number
- NCT02111096
- Locations
- 🇺🇸
Midwest CRC, Crystal Lake, Illinois, United States
🇺🇸Iderc, P.L.C., Des Moines, Iowa, United States
🇺🇸Cotton O'Neil Clinic, Topeka, Kansas, United States
A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants
- Conditions
- Healthy Volunteers
- Interventions
- Biological: Insulin Lispro
- First Posted Date
- 2014-04-10
- Last Posted Date
- 2015-05-21
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 38
- Registration Number
- NCT02111083
- Locations
- 🇸🇬
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore, Singapore
A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants
- First Posted Date
- 2014-04-09
- Last Posted Date
- 2018-07-16
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 15
- Registration Number
- NCT02109042
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas, Texas, United States
A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- First Posted Date
- 2014-04-09
- Last Posted Date
- 2019-03-06
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 24
- Registration Number
- NCT02109029
- Locations
- 🇦🇹
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Graz, Austria